Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RYAN H ENGEL

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1740336718
CMS profile
214750
Location
ZION, IL

General Payments · PY2018–2024

$10,082.30

  • Reported across 63 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$8,022.11

39 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $7,402.50 11
Food and Beverage $619.61 28

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,081.77 13
PY2022 $20.28 1
PY2023 $958.14 10
PY2024 $8,022.11 39

Payment records · PY2024 (39)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $525.00 03/06/2024 Consulting Fee Undisputed 01/23/2026 1105850102 CMS
AstraZeneca Pharmaceuticals LP $525.00 05/22/2024 Consulting Fee Undisputed 01/23/2026 1105847039 CMS
AstraZeneca Pharmaceuticals LP $525.00 06/25/2024 Consulting Fee Undisputed 01/23/2026 1104630744 CMS
AstraZeneca Pharmaceuticals LP $525.00 08/01/2024 Consulting Fee Undisputed 01/23/2026 1105783288 CMS
AstraZeneca Pharmaceuticals LP $525.00 08/26/2024 Consulting Fee Undisputed 01/23/2026 1104197349 CMS
AstraZeneca Pharmaceuticals LP $525.00 10/01/2024 Consulting Fee Undisputed 01/23/2026 1105515049 CMS
AstraZeneca Pharmaceuticals LP $525.00 12/12/2024 Consulting Fee Undisputed 01/23/2026 1105403271 CMS
BeiGene USA, Inc. $675.00 11/26/2024 Consulting Fee Undisputed 01/23/2026 1120857691 CMS
Celgene Corporation $27.34 06/20/2024 Food and Beverage Undisputed 01/23/2026 1101142764 CMS
Celgene Corporation $26.37 10/10/2024 Food and Beverage Undisputed 01/23/2026 1101142776 CMS
Daiichi Sankyo Inc. $24.77 03/06/2024 Food and Beverage Undisputed 01/23/2026 1089419262 CMS
Daiichi Sankyo Inc. $1,110.00 04/24/2024 Consulting Fee Undisputed 01/23/2026 1089419254 CMS
Daiichi Sankyo Inc. $26.68 05/06/2024 Food and Beverage Undisputed 01/23/2026 1089419270 CMS
Daiichi Sankyo Inc. $555.00 05/15/2024 Consulting Fee Undisputed 01/23/2026 1089419256 CMS
Daiichi Sankyo Inc. $27.44 07/25/2024 Food and Beverage Undisputed 01/23/2026 1089419272 CMS
Daiichi Sankyo Inc. $28.09 10/01/2024 Food and Beverage Undisputed 01/23/2026 1089419246 CMS
Daiichi Sankyo Inc. $28.53 10/08/2024 Food and Beverage Undisputed 01/23/2026 1089419248 CMS
Daiichi Sankyo Inc. $1,387.50 10/16/2024 Consulting Fee Undisputed 01/23/2026 1089419258 CMS
Daiichi Sankyo Inc. $29.99 10/30/2024 Food and Beverage Undisputed 01/23/2026 1089419250 CMS
Daiichi Sankyo Inc. $3.06 11/25/2024 Food and Beverage Undisputed 01/23/2026 1089419252 CMS
Genentech USA, Inc. $26.71 06/28/2024 Food and Beverage Undisputed 01/23/2026 1133103324 CMS
Genentech USA, Inc. $17.49 08/21/2024 Food and Beverage Undisputed 01/23/2026 1133103320 CMS
Gilead Sciences, Inc. $22.78 05/30/2024 Food and Beverage Undisputed 01/23/2026 1133643518 CMS
Janssen Pharmaceuticals, Inc $23.18 05/01/2024 Food and Beverage Undisputed 01/23/2026 1078014694 CMS
Merck Sharp & Dohme LLC $24.89 01/25/2024 Food and Beverage Undisputed 01/23/2026 1141668138 CMS
Merck Sharp & Dohme LLC $19.67 03/20/2024 Food and Beverage Undisputed 01/23/2026 1141858230 CMS
Merck Sharp & Dohme LLC $22.22 04/17/2024 Food and Beverage Undisputed 01/23/2026 1141668140 CMS
Merck Sharp & Dohme LLC $25.37 07/18/2024 Food and Beverage Undisputed 01/23/2026 1141668144 CMS
Merck Sharp & Dohme LLC $15.26 07/24/2024 Food and Beverage Undisputed 01/23/2026 1141858228 CMS
Merck Sharp & Dohme LLC $21.50 08/13/2024 Food and Beverage Undisputed 01/23/2026 1141668142 CMS
Merck Sharp & Dohme LLC $12.84 09/10/2024 Food and Beverage Undisputed 01/23/2026 1141668136 CMS
Novartis Pharmaceuticals Corporation $23.76 06/21/2024 Food and Beverage Undisputed 01/23/2026 1086958415 CMS
Novartis Pharmaceuticals Corporation $20.41 08/15/2024 Food and Beverage Undisputed 01/23/2026 1086958429 CMS
PFIZER INC. $17.46 05/08/2024 Food and Beverage Undisputed 01/23/2026 1131502599 CMS
PFIZER INC. $19.85 07/22/2024 Food and Beverage Undisputed 01/23/2026 1131783852 CMS
Takeda Pharmaceuticals U.S.A., Inc. $19.72 07/10/2024 Food and Beverage Undisputed 01/23/2026 1137540640 CMS
Tempus AI, Inc $26.31 02/22/2024 Food and Beverage Undisputed 01/23/2026 1150164293 CMS
Tempus AI, Inc $19.91 05/29/2024 Food and Beverage Undisputed 01/23/2026 1150164295 CMS
Tempus AI, Inc $18.01 06/19/2024 Food and Beverage Undisputed 01/23/2026 1150164297 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.